Global RNA-Based Therapeutics and Vaccines Market Growth (Status and Outlook) 2022-2028

Global RNA-Based Therapeutics and Vaccines Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNA-Based Therapeutics and Vaccines Market Size 2017-2028
2.1.2 RNA-Based Therapeutics and Vaccines Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 RNA-Based Therapeutics and Vaccines Segment by Type
2.2.1 RNA-Based Therapeutics
2.2.2 RNA-Based Vaccines
2.3 RNA-Based Therapeutics and Vaccines Market Size by Type
2.3.1 RNA-Based Therapeutics and Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2022)
2.4 RNA-Based Therapeutics and Vaccines Segment by Application
2.4.1 Oncology
2.4.2 Immunology
2.4.3 Ophthalmology
2.4.4 Cardiovascular Diseases
2.4.5 Infectious Diseases
2.4.6 Genetic Diseases
2.4.7 Others
2.5 RNA-Based Therapeutics and Vaccines Market Size by Application
2.5.1 RNA-Based Therapeutics and Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2022)
3 RNA-Based Therapeutics and Vaccines Market Size by Player
3.1 RNA-Based Therapeutics and Vaccines Market Size Market Share by Players
3.1.1 Global RNA-Based Therapeutics and Vaccines Revenue by Players (2020-2022)
3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2020-2022)
3.2 Global RNA-Based Therapeutics and Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA-Based Therapeutics and Vaccines by Regions
4.1 RNA-Based Therapeutics and Vaccines Market Size by Regions (2017-2022)
4.2 Americas RNA-Based Therapeutics and Vaccines Market Size Growth (2017-2022)
4.3 APAC RNA-Based Therapeutics and Vaccines Market Size Growth (2017-2022)
4.4 Europe RNA-Based Therapeutics and Vaccines Market Size Growth (2017-2022)
4.5 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Growth (2017-2022)
5 Americas
5.1 Americas RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022)
5.2 Americas RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022)
5.3 Americas RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA-Based Therapeutics and Vaccines Market Size by Region (2017-2022)
6.2 APAC RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022)
6.3 APAC RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe RNA-Based Therapeutics and Vaccines by Country (2017-2022)
7.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022)
7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa RNA-Based Therapeutics and Vaccines by Region (2017-2022)
8.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022)
8.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global RNA-Based Therapeutics and Vaccines Market Forecast
10.1 Global RNA-Based Therapeutics and Vaccines Forecast by Regions (2023-2028)
10.1.1 Global RNA-Based Therapeutics and Vaccines Forecast by Regions (2023-2028)
10.1.2 Americas RNA-Based Therapeutics and Vaccines Forecast
10.1.3 APAC RNA-Based Therapeutics and Vaccines Forecast
10.1.4 Europe RNA-Based Therapeutics and Vaccines Forecast
10.1.5 Middle East & Africa RNA-Based Therapeutics and Vaccines Forecast
10.2 Americas RNA-Based Therapeutics and Vaccines Forecast by Country (2023-2028)
10.2.1 United States RNA-Based Therapeutics and Vaccines Market Forecast
10.2.2 Canada RNA-Based Therapeutics and Vaccines Market Forecast
10.2.3 Mexico RNA-Based Therapeutics and Vaccines Market Forecast
10.2.4 Brazil RNA-Based Therapeutics and Vaccines Market Forecast
10.3 APAC RNA-Based Therapeutics and Vaccines Forecast by Region (2023-2028)
10.3.1 China RNA-Based Therapeutics and Vaccines Market Forecast
10.3.2 Japan RNA-Based Therapeutics and Vaccines Market Forecast
10.3.3 Korea RNA-Based Therapeutics and Vaccines Market Forecast
10.3.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Forecast
10.3.5 India RNA-Based Therapeutics and Vaccines Market Forecast
10.3.6 Australia RNA-Based Therapeutics and Vaccines Market Forecast
10.4 Europe RNA-Based Therapeutics and Vaccines Forecast by Country (2023-2028)
10.4.1 Germany RNA-Based Therapeutics and Vaccines Market Forecast
10.4.2 France RNA-Based Therapeutics and Vaccines Market Forecast
10.4.3 UK RNA-Based Therapeutics and Vaccines Market Forecast
10.4.4 Italy RNA-Based Therapeutics and Vaccines Market Forecast
10.4.5 Russia RNA-Based Therapeutics and Vaccines Market Forecast
10.5 Middle East & Africa RNA-Based Therapeutics and Vaccines Forecast by Region (2023-2028)
10.5.1 Egypt RNA-Based Therapeutics and Vaccines Market Forecast
10.5.2 South Africa RNA-Based Therapeutics and Vaccines Market Forecast
10.5.3 Israel RNA-Based Therapeutics and Vaccines Market Forecast
10.5.4 Turkey RNA-Based Therapeutics and Vaccines Market Forecast
10.5.5 GCC Countries RNA-Based Therapeutics and Vaccines Market Forecast
10.6 Global RNA-Based Therapeutics and Vaccines Forecast by Type (2023-2028)
10.7 Global RNA-Based Therapeutics and Vaccines Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Information
11.1.2 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Alnylam Pharmaceuticals Main Business Overview
11.1.5 Alnylam Pharmaceuticals Latest Developments
11.2 Arbutus Biopharma
11.2.1 Arbutus Biopharma Company Information
11.2.2 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Offered
11.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Arbutus Biopharma Main Business Overview
11.2.5 Arbutus Biopharma Latest Developments
11.3 Arrowhead Pharmaceuticals
11.3.1 Arrowhead Pharmaceuticals Company Information
11.3.2 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Arrowhead Pharmaceuticals Main Business Overview
11.3.5 Arrowhead Pharmaceuticals Latest Developments
11.4 BioNTech
11.4.1 BioNTech Company Information
11.4.2 BioNTech RNA-Based Therapeutics and Vaccines Product Offered
11.4.3 BioNTech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech Latest Developments
11.5 CureVac
11.5.1 CureVac Company Information
11.5.2 CureVac RNA-Based Therapeutics and Vaccines Product Offered
11.5.3 CureVac RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 CureVac Main Business Overview
11.5.5 CureVac Latest Developments
11.6 Dicerna Pharmaceuticals
11.6.1 Dicerna Pharmaceuticals Company Information
11.6.2 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Dicerna Pharmaceuticals Main Business Overview
11.6.5 Dicerna Pharmaceuticals Latest Developments
11.7 Regulus Therapeutics
11.7.1 Regulus Therapeutics Company Information
11.7.2 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
11.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Regulus Therapeutics Main Business Overview
11.7.5 Regulus Therapeutics Latest Developments
11.8 Marina Biotech
11.8.1 Marina Biotech Company Information
11.8.2 Marina Biotech RNA-Based Therapeutics and Vaccines Product Offered
11.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Marina Biotech Main Business Overview
11.8.5 Marina Biotech Latest Developments
11.9 MiRagen Therapeutics
11.9.1 MiRagen Therapeutics Company Information
11.9.2 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
11.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 MiRagen Therapeutics Main Business Overview
11.9.5 MiRagen Therapeutics Latest Developments
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Information
11.10.2 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
11.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Moderna Therapeutics Main Business Overview
11.10.5 Moderna Therapeutics Latest Developments
11.11 Quark Pharmaceuticals
11.11.1 Quark Pharmaceuticals Company Information
11.11.2 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Quark Pharmaceuticals Main Business Overview
11.11.5 Quark Pharmaceuticals Latest Developments
11.12 Roche
11.12.1 Roche Company Information
11.12.2 Roche RNA-Based Therapeutics and Vaccines Product Offered
11.12.3 Roche RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Roche Main Business Overview
11.12.5 Roche Latest Developments
11.13 Sylentis
11.13.1 Sylentis Company Information
11.13.2 Sylentis RNA-Based Therapeutics and Vaccines Product Offered
11.13.3 Sylentis RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Sylentis Main Business Overview
11.13.5 Sylentis Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. RNA-Based Therapeutics and Vaccines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of RNA-Based Therapeutics
Table 3. Major Players of RNA-Based Vaccines
Table 4. RNA-Based Therapeutics and Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2022)
Table 7. RNA-Based Therapeutics and Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2022)
Table 10. Global RNA-Based Therapeutics and Vaccines Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Player (2020-2022)
Table 12. RNA-Based Therapeutics and Vaccines Key Players Head office and Products Offered
Table 13. RNA-Based Therapeutics and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global RNA-Based Therapeutics and Vaccines Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Regions (2017-2022)
Table 18. Americas RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Country (2017-2022)
Table 20. Americas RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2022)
Table 22. Americas RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2022)
Table 24. APAC RNA-Based Therapeutics and Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Region (2017-2022)
Table 26. APAC RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2022)
Table 28. APAC RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2022)
Table 30. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Country (2017-2022)
Table 32. Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2022)
Table 34. Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of RNA-Based Therapeutics and Vaccines
Table 43. Key Market Challenges & Risks of RNA-Based Therapeutics and Vaccines
Table 44. Key Industry Trends of RNA-Based Therapeutics and Vaccines
Table 45. Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Application (2023-2028)
Table 51. Alnylam Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 52. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 53. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Alnylam Pharmaceuticals Main Business
Table 55. Alnylam Pharmaceuticals Latest Developments
Table 56. Arbutus Biopharma Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 57. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Offered
Table 58. Arbutus Biopharma Main Business
Table 59. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Arbutus Biopharma Latest Developments
Table 61. Arrowhead Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 62. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 63. Arrowhead Pharmaceuticals Main Business
Table 64. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Arrowhead Pharmaceuticals Latest Developments
Table 66. BioNTech Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 67. BioNTech RNA-Based Therapeutics and Vaccines Product Offered
Table 68. BioNTech Main Business
Table 69. BioNTech RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. BioNTech Latest Developments
Table 71. CureVac Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 72. CureVac RNA-Based Therapeutics and Vaccines Product Offered
Table 73. CureVac Main Business
Table 74. CureVac RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. CureVac Latest Developments
Table 76. Dicerna Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 77. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 78. Dicerna Pharmaceuticals Main Business
Table 79. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Dicerna Pharmaceuticals Latest Developments
Table 81. Regulus Therapeutics Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 82. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
Table 83. Regulus Therapeutics Main Business
Table 84. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Regulus Therapeutics Latest Developments
Table 86. Marina Biotech Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 87. Marina Biotech RNA-Based Therapeutics and Vaccines Product Offered
Table 88. Marina Biotech Main Business
Table 89. Marina Biotech RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Marina Biotech Latest Developments
Table 91. MiRagen Therapeutics Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 92. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
Table 93. MiRagen Therapeutics Main Business
Table 94. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. MiRagen Therapeutics Latest Developments
Table 96. Moderna Therapeutics Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 97. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
Table 98. Moderna Therapeutics Main Business
Table 99. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Moderna Therapeutics Latest Developments
Table 101. Quark Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 102. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 103. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Quark Pharmaceuticals Main Business
Table 105. Quark Pharmaceuticals Latest Developments
Table 106. Roche Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 107. Roche RNA-Based Therapeutics and Vaccines Product Offered
Table 108. Roche Main Business
Table 109. Roche RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Roche Latest Developments
Table 111. Sylentis Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 112. Sylentis RNA-Based Therapeutics and Vaccines Product Offered
Table 113. Sylentis Main Business
Table 114. Sylentis RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Sylentis Latest Developments
List of Figures
Figure 1. RNA-Based Therapeutics and Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2021
Figure 7. RNA-Based Therapeutics and Vaccines in Oncology
Figure 8. Global RNA-Based Therapeutics and Vaccines Market: Oncology (2017-2022) & ($ Millions)
Figure 9. RNA-Based Therapeutics and Vaccines in Immunology
Figure 10. Global RNA-Based Therapeutics and Vaccines Market: Immunology (2017-2022) & ($ Millions)
Figure 11. RNA-Based Therapeutics and Vaccines in Ophthalmology
Figure 12. Global RNA-Based Therapeutics and Vaccines Market: Ophthalmology (2017-2022) & ($ Millions)
Figure 13. RNA-Based Therapeutics and Vaccines in Cardiovascular Diseases
Figure 14. Global RNA-Based Therapeutics and Vaccines Market: Cardiovascular Diseases (2017-2022) & ($ Millions)
Figure 15. RNA-Based Therapeutics and Vaccines in Infectious Diseases
Figure 16. Global RNA-Based Therapeutics and Vaccines Market: Infectious Diseases (2017-2022) & ($ Millions)
Figure 17. RNA-Based Therapeutics and Vaccines in Genetic Diseases
Figure 18. Global RNA-Based Therapeutics and Vaccines Market: Genetic Diseases (2017-2022) & ($ Millions)
Figure 19. RNA-Based Therapeutics and Vaccines in Others
Figure 20. Global RNA-Based Therapeutics and Vaccines Market: Others (2017-2022) & ($ Millions)
Figure 21. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2021
Figure 22. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Player in 2021
Figure 23. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Regions (2017-2022)
Figure 24. Americas RNA-Based Therapeutics and Vaccines Market Size 2017-2022 ($ Millions)
Figure 25. APAC RNA-Based Therapeutics and Vaccines Market Size 2017-2022 ($ Millions)
Figure 26. Europe RNA-Based Therapeutics and Vaccines Market Size 2017-2022 ($ Millions)
Figure 27. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size 2017-2022 ($ Millions)
Figure 28. Americas RNA-Based Therapeutics and Vaccines Value Market Share by Country in 2021
Figure 29. Americas RNA-Based Therapeutics and Vaccines Consumption Market Share by Type in 2021
Figure 30. Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2021
Figure 31. United States RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 32. Canada RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 33. Mexico RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 34. Brazil RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 35. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Region in 2021
Figure 36. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2021
Figure 37. China RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 38. Japan RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 39. Korea RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 40. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 41. India RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 42. Australia RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 43. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Country in 2021
Figure 44. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2021
Figure 45. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2021
Figure 46. Germany RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 47. France RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 48. UK RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 49. Italy RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 50. Russia RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 51. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Region in 2021
Figure 52. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2021
Figure 53. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2021
Figure 54. Egypt RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 55. South Africa RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 56. Israel RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 57. Turkey RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 58. GCC Country RNA-Based Therapeutics and Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 59. Americas RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 60. APAC RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 61. Europe RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 62. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 63. United States RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 64. Canada RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 65. Mexico RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 66. Brazil RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 67. China RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 68. Japan RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 69. Korea RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 70. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 71. India RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 72. Australia RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 73. Germany RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 74. France RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 75. UK RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 76. Italy RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 77. Russia RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 78. Spain RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 79. Egypt RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 80. South Africa RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 81. Israel RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 82. Turkey RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)
Figure 83. GCC Countries RNA-Based Therapeutics and Vaccines Market Size 2023-2028 ($ Millions)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs